Network Insights Methodology Get Access

FDA

ORG Government / Drug & Device Regulation Momentum 29.7 NORMAL Primary: Spectral Shift

FDA (6,900 employees, $6.5B budget) regulates 20% of US consumer spending across drugs, devices, and food. In April 2026, accelerated trial transparency enforcement and approved 12+ novel therapies including first FSGS drug, gene therapy for leukocyte adhesion deficiency, and genome editing guidance.

FDA leadership search underway for new biologics and vaccines division head; no M&A activity.
-0.22
PSI Score
29.7
Momentum
1%
Confidence
26
Connections
Connected Entities
Watch This Entity
PSI Intelligence
30-Day Trend
2026-03-27 2026-04-26 26 0 Degree Mentions
Signal Decomposition
Attention Cascade
-1.944
Narrative Drift
0.037
Spectral Shift
831.349
Sentiment-Momentum Divergence
0.000
Source Concentration
0.924
Peer Comparison
N/A
Sector Rank
+0.00
Peer Z-Score
0%
Sector Percentile
Predicted Links
Predicted ConnectionProbability
PentagonX-SECTOR 0.997
UKX-SECTOR 0.994
TreasuryX-SECTOR 0.993
Network Analysis
26 Degree Centrality
Centrality History
2026-03-27 2026-04-26 26 0 Degree Mentions
EntityWeight StatusFirst Seen
United States 20 STABLE
HHS 14 STRENGTHENED
Novo Nordisk 13 NEW
RFK Jr. 9 NEW
Eli Lilly 8 NEW
China 6 STABLE
Donald Trump 5 STABLE
White House 5 STABLE
Pfizer 5 STABLE
WASHINGTON 5 STABLE
Iran 4 STABLE
President 4 STABLE
GOP 4 STRENGTHENED
AP 4 STABLE
CMS 4 STRENGTHENED
Europe 3 STABLE
Sanofi 3 NEW
Illinois 3 NEW
Senate 3 STABLE
Bloomberg 3 STABLE
Massachusetts 3 NEW
CEO 2 STABLE
DHS 2 STABLE
Education Department 2 NEW
Gaza 2 NEW
Israel 2 STABLE
NPR 2 NEW
Ohio 2 NEW
NEW YORK 2 STABLE
Americans 2 STABLE
Article Coverage (0)
DateLaneTitle

Request Access

Full PSI intelligence, network analysis, EDGAR filings, and predicted links require an access token.

Data as of 2026-04-26 ← Intelligence Network